Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema

Interest of the Ultrasound Follow-up of Lymphedema by Elastography Assessment and Cutaneous and Subcutaneous Thickness Measurement During Intensive Treatment of Lymphedema.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05186142

Acronym

ELASTOLYMPH

Enrollment

Registered

2022-01-11

Start date

2019-05-01

Completion date

2019-10-20

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Lymphedema, Lymphedema

Keywords

Skin suppleness, Elastography, lymphedema, Manual Lymphatic Drainage

Brief summary

Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema Hence the importance of evaluating the impact of an intensive five-day decongestive treatment on lymphedema in terms of cutaneous flexibility and edema regression. Patients who are undergoing intensive decongestive treatment for four or five days in the department perform an ultrasound check/examiantion on the first day. During this echography, in 5 usual measurement points are made an ultrasound image recording (for measurement of cutaneous and subcutaneous thicknesses) and an elastography sequence (an instantaneous measurement). The study hypothesis is to note that intensive decongestive treatment has an impact on tissues flexibility and cutaneous and subcutaneous thickness. No many authors discussed this suject, hence the interest of this study. All the data collected and the results obtained will serve for further studies.

Interventions

OTHERUltrasonography / Ultrasound elastography

Ultrasonography / Ultrasound elastography

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Major patients with unilateral or bilateral lymphedema of the lower limb (s), stage II or III, of primary or secondary origin * Major patients with admitted for the realization of an Intensive Decongestive Treatment (TDI) of three to five days in the lymphology unit of the Saint Eloi hospital, of Montpellier UHC.

Exclusion criteria

* Patients with different lymphedema localisation than the lower limbs * Patient with amputated * patient not consenting or included in another clinical research study.

Design outcomes

Primary

Measure	Time frame	Description
number of Elastography	day 1 (pre treatment)	number of Elastography

Secondary

Measure	Time frame	Description
number of Cutaneous thicknesses	day 1 (pre treatment)	number of Cutaneous thicknesses
number of Subcutaneous thicknesses	day 1 (pre treatment)	number of Subcutaneous thicknesses
number of Limb volumetry	day 1 (pre treatment)	number of Limb volumetry in milliliter

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026